P. Desjeux, Worldwide increasing risk factors for leishmaniasis, Medical Microbiology and Immunology, vol.190, issue.1-2, pp.77-79, 2001.
DOI : 10.1007/s004300100085

J. Alvar, S. Yactayo, and C. Bern, Leishmaniasis and poverty, Trends in Parasitology, vol.22, issue.12, pp.552-557, 2006.
DOI : 10.1016/j.pt.2006.09.004

P. Buffet and G. Morizot, Cutaneous leishmaniasis in France: towards the end of injectable therapy?, Bull Soc Pathol Exot, vol.96, pp.383-388, 2003.

A. Magill, Cutaneous leishmaniasis in the returning traveler, Infectious Disease Clinics of North America, vol.19, issue.1, pp.241-266, 2005.
DOI : 10.1016/j.idc.2004.11.005

A. Bryceson, Therapy in man, The leishmaniases, pp.847-869, 1987.

T. Garnier and S. Croft, Topical treatment for cutaneous leishmaniasis, Current opinion in investigational drugs, vol.3, pp.538-544, 2002.

A. Asilian, A. Sadeghinia, G. Faghihi, A. Momeni, and A. Harandi, The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis, Annals of Tropical Medicine & Parasitology, vol.10, issue.5, pp.493-498, 2003.
DOI : 10.1111/j.1365-4362.1996.tb03669.x

J. El-on, R. Livshin, Z. Even-paz, D. Hamburger, and L. Weinrauch, Topical Treatment of Cutaneous Leishmaniasis, Journal of Investigative Dermatology, vol.87, issue.2, pp.284-288, 1986.
DOI : 10.1111/1523-1747.ep12696697

J. El-on, S. Halevy, M. Grunwald, and L. Weinrauch, Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study, Journal of the American Academy of Dermatology, vol.27, issue.2, pp.227-231, 1992.
DOI : 10.1016/0190-9622(92)70175-F

S. El-safi, A. Murphy, A. Bryceson, and R. Neal, A double-blind clinical trial of the treatment of cutaneous leishmaniasis with paromomycin ointment, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.84, issue.5, pp.690-691, 1990.
DOI : 10.1016/0035-9203(90)90146-6

A. Bryceson, A. Murphy, and A. Moody, Treatment of ???Old World??? cutaneous leishmaniasis with aminosidine ointment: results of an open study in London, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.2, pp.226-228, 1994.
DOI : 10.1016/0035-9203(94)90308-5

A. Asilian, T. Jalayer, J. Whitworth, R. Ghasemi, and M. Nilforooshzadeh, A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran, Am J Trop Med Hyg, vol.53, pp.648-651, 1995.

B. Salah, A. Zakraoui, H. Zaatour, A. Ftaiti, A. Zaafouri et al., A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment, Am J Trop Med Hyg, vol.53, pp.162-166, 1995.

J. Soto, J. Toledo, P. Gutierrez, M. Arboleda, and R. Nicholls, Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): Phase 2 pilot study, Am J Trop Med Hyg, vol.66, pp.147-151, 2002.

U. Mrowietz, M. Graeber, M. Brautigam, M. Thurston, and A. Wagenaar, The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion, British Journal of Dermatology, vol.38, issue.2, pp.992-996, 1998.
DOI : 10.1001/archderm.131.5.561

F. Iraji and A. Sadeghinia, Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran, Annals of Tropical Medicine & Parasitology, vol.99, issue.1, pp.3-9, 2005.
DOI : 10.1046/j.1365-4362.1997.00022.x

G. Krause and A. Kroeger, Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.88, issue.1, pp.92-94, 1994.
DOI : 10.1016/0035-9203(94)90517-7

Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, and G. Milon, A Natural Model of Leishmania major Infection Reveals a Prolonged "Silent" Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity, The Journal of Immunology, vol.165, issue.2, pp.969-977, 2000.
DOI : 10.4049/jimmunol.165.2.969

S. Belazzoug and R. Neal, Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.80, issue.4, pp.670-671, 1986.
DOI : 10.1016/0035-9203(86)90176-8

T. Lang, S. Goyard, M. Lebastard, and G. Milon, Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice, Cellular Microbiology, vol.7, issue.3, pp.383-392, 2005.
DOI : 10.1016/0022-1759(87)90115-3

S. Goyard, H. Segawa, J. Gordon, M. Showalter, and R. Duncan, An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans, Molecular and Biochemical Parasitology, vol.130, issue.1, pp.31-42, 2003.
DOI : 10.1016/S0166-6851(03)00142-7

G. Spä-th and S. Beverley, A Lipophosphoglycan-Independent Method for Isolation of Infective Leishmania Metacyclic Promastigotes by Density Gradient Centrifugation, Experimental Parasitology, vol.99, issue.2, pp.97-103, 2001.
DOI : 10.1006/expr.2001.4656

M. Grogl, B. Schuster, W. Ellis, and J. Berman, Successful Topical Treatment of Murine Cutaneous Leishmaniasis with a Combination of Paromomycin (Aminosidine) and Gentamicin, The Journal of Parasitology, vol.85, issue.2, pp.354-359, 1999.
DOI : 10.2307/3285646

V. Leclercq, M. Lebastard, Y. Belkaid, J. Louis, and G. Milon, The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissuedependent pattern controlled by the Lsh and MHC loci, J Immunol, vol.157, pp.4537-4545, 1996.

C. Sunderkotter, M. Kunz, K. Steinbrink, G. Meinardus-hager, and M. Goebeler, Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo, J Immunol, vol.151, pp.4891-4901, 1993.

L. Strijbosch, W. Buurman, R. Does, P. Zinken, and G. Groenewegen, Limiting dilution assays, Journal of Immunological Methods, vol.97, issue.1, pp.133-140, 1987.
DOI : 10.1016/0022-1759(87)90115-3

C. Taswell, Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis, J Immunol, vol.126, pp.1614-1619, 1981.

E. Berardesca, G. Vignoli, D. Fideli, and H. Maibach, Effect of Occlusive Dressings on the Stratum Corneum Water Holding Capacity, The American Journal of the Medical Sciences, vol.304, issue.1, pp.25-28, 1992.
DOI : 10.1097/00000441-199207000-00007

S. Bell, M. Schaller, and M. Rocken, Occlusive paromomycin for cutaneous leishmaniasis [see comments], Lancet, vol.349, p.29, 1997.

J. Saurat, Cutaneous Leishmaniasis Treated With Controlled Localized Heating, Archives of Dermatology, vol.129, issue.4, pp.510-510, 1993.
DOI : 10.1001/archderm.1993.01680250126022

J. Berman, Current treatment approaches to leishmaniasis, Current Opinion in Infectious Diseases, vol.16, issue.5, pp.397-401, 2003.
DOI : 10.1097/00001432-200310000-00005

P. Tulkens and A. Trouet, The uptake and intracellular accumulation of aminoglycoside antibiotics in lysosomes of cultured rat fibroblasts, Biochemical Pharmacology, vol.27, issue.4, pp.415-424, 1978.
DOI : 10.1016/0006-2952(78)90370-2

P. Tulkens, Intracellular distribution and activity of antibiotics, European Journal of Clinical Microbiology & Infectious Diseases, vol.29, issue.Supplement D, pp.100-106, 1991.
DOI : 10.1007/BF01964420

L. Nicolas, S. Sidjanski, J. Colle, and G. Milon, Leishmania major Reaches Distant Cutaneous Sites Where It Persists Transiently while Persisting Durably in the Primary Dermal Site and Its Draining Lymph Node: a Study with Laboratory Mice, Infection and Immunity, vol.68, issue.12, pp.6561-6566, 2000.
DOI : 10.1128/IAI.68.12.6561-6566.2000